Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : VLP-AAV007
| Cat. No. | VLP-AAV007 |
| Description | AAV3 virus-like particles are empty capsids of AAV serotype 3 that do not contain any genomic material and can be used as reference materials and other applications. |
| Applications | Adeno-associated virus (AAV) serotype 3 (AAV3) virus-like particles (VLPs), which are essentially empty capsids, have a variety of applications, particularly in the areas of gene therapy and molecular biology research. Here are some key applications: Immunogenicity studies: AAV3 VLPs can be used to study immune responses elicited by the capsid itself, without the confounding effects of the viral genome. This helps understand and mitigate immune responses that may neutralize therapeutic AAV vectors. Standardization and control studies: Empty AAV3 capsids can be used as controls or standards in experiments, helping to distinguish the effects of capsid proteins from the delivered genetic material. Manufacturing optimization: By analyzing the efficiency of producing empty and filled capsids, researchers can optimize large-scale production of AAV vectors, which is critical to the commercial viability of gene therapy products. Biodistribution and pharmacokinetics: Since they contain no genetic material, AAV3 VLPs can be used to study the biodistribution and pharmacokinetics of the capsid itself in vivo, providing insight into how the vector spreads and persists in biological systems. Safety studies: They can be used in preclinical safety studies to assess the potential for toxicity or other adverse effects associated with the capsid itself, independent of any delivered therapeutic gene. Antigenicity testing: Researchers can use AAV3 VLPs to study antigen-antibody interactions and develop assays to detect AAV3 neutralizing antibodies, which is important for both clinical and research purposes. |
| Storage | -80˚C |
| Shipping | Dry ice |
AAV3 refers to adeno-associated virus serotype 3 and is one of the various serotypes of adeno-associated virus (AAV). AAV is a small, non-enveloped virus with a single-stranded DNA genome known for its ability to infect both dividing and non-dividing cells. They are often used as vectors for gene therapy due to their safety profile and ability to achieve long-term gene expression without eliciting a significant immune response.
AAV3 virus-like particles (VLPs) are specially designed empty capsids of the AAV3 serotype that do not contain any genomic material. These particles retain the structural and antigenic characteristics of native AAV3, making them a valuable tool for a variety of research and therapeutic purposes. AAV3 VLPs consist of the viral capsid proteins VP1, VP2, and VP3, which assemble into a 60-subunit icosahedral structure. This structure is identical to the complete AAV3 particle, only lacking the single-stranded DNA genome. The absence of genetic material within these capsids precludes the risk of off-target gene delivery or potential insertional mutagenesis, thereby increasing their safety.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
Great! The AAV3 VLPs (empty capsids) we receive are of exceptional quality and purity.
One of the most impressive aspects of the AAV3 Virus-Like Particles was their consistency and stability. Across multiple batches, we observed uniform performance, which is crucial for longitudinal studies and comparative research.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.